Revenue: The sum of all revenue fields included for a company's operating activities.
Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-19.65M |
|
-- |
|
-- |
|
$20.60M |
|
$-20.60M |
|
$0.92M |
|
$-19.68M |
|
$-19.68M |
|
$-19.66M |
|
$-19.66M |
|
$-19.66M |
|
$-19.66M |
|
$-20.60M |
|
$-18.57M |
|
40.27M |
|
40.27M |
|
$-0.49 |
|
$-0.49 |
|
| Balance Sheet Financials | |
$109.88M |
|
$6.20M |
|
$32.11M |
|
$142.00M |
|
$11.98M |
|
-- |
|
$14.43M |
|
$26.40M |
|
$115.59M |
|
$94.44M |
|
$115.59M |
|
40.34M |
|
| Cash Flow Statement Financials | |
$-14.90M |
|
$-0.01M |
|
$0.00M |
|
$112.40M |
|
$100.58M |
|
$-11.82M |
|
$0.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.18 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.91M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-17.01% |
|
-20.82% |
|
-13.84% |
|
-17.01% |
|
$2.87 |
|
$-0.37 |
|
$-0.37 |
|